Product Overview

Gestone 50 mg Injection is a pharmaceutical preparation that contains progesterone as the active ingredient. It is manufactured by Ferring Pharmaceuticals, a global leader in reproductive health and endocrinology. The medication is supplied in a 1 ml vial and is indicated for the treatment of female infertility and as part of hormone replacement therapy in selected clinical scenarios. Pack sizes are available in 10, 20, or 30 injections per box, allowing clinicians to tailor treatment plans to individual patient needs.

What is Gestone 50 mg Injection?

Gestone 50 mg Injection is a synthetic form of the natural hormone progesterone. Progesterone plays a critical role in regulating the menstrual cycle, supporting early pregnancy, and maintaining the endometrium for implantation. In clinical practice, the injectable form is used when rapid absorption and predictable blood levels are required, such as in assisted reproductive technologies or in women who cannot take oral medication due to gastrointestinal intolerance. The product is classified under the category of female infertility treatments and hormone replacement therapy, reflecting its dual role in fertility support and endocrine management.

Uses and Benefits

The primary indication for Gestone 50 mg Injection is to improve endometrial receptivity in women undergoing in‑vitro fertilization (IVF) or other assisted reproductive procedures. By providing a steady supply of progesterone, the injection helps prepare the uterine lining for embryo implantation, thereby increasing the chances of successful pregnancy. In hormone replacement therapy, Gestone can be used to counteract estrogen‑only regimens that might otherwise lead to endometrial hyperplasia. Benefits include a well‑characterized safety profile, predictable pharmacokinetics, and the convenience of a once‑daily or as‑prescribed dosing schedule. Clinicians also value the ability to adjust dose volume based on patient response, which is especially useful in individualized fertility protocols.

How It Works

Progesterone exerts its effects by binding to intracellular progesterone receptors, which then translocate to the nucleus and modulate gene expression. In the uterus, this leads to secretory changes that transform the endometrium from a proliferative to a secretory state, a prerequisite for successful embryo implantation. The synthetic formulation in Gestone mimics the activity of endogenous progesterone but is designed to have a consistent dose and duration of action. Once administered intramuscularly or subcutaneously, the medication is absorbed into the bloodstream and distributed to target tissues, where it supports the luteal phase or maintains hormonal balance in hormone‑replacement regimens. The mechanism is well documented in scientific literature, including reviews from the National Center for Biotechnology Information.

Dosage Guidelines

Dosage of Gestone 50 mg Injection is typically individualized based on the clinical indication and patient response. For fertility support, a common regimen involves a single 50 mg injection administered daily for a defined period, often beginning on the day of oocyte retrieval or as directed by the treating physician. In hormone replacement therapy, dosing may be less frequent, such as twice weekly, depending on the therapeutic goal. It is essential that patients follow the dosing schedule provided by their healthcare provider and not adjust the dose without medical guidance. The medication should be stored at controlled room temperature and protected from light. Detailed dosing charts are available through professional fertility networks and can be referenced for clinical planning.

Side Effects

Like all medications, Gestone 50 mg Injection may cause adverse effects. The most frequently reported side effects include mild injection‑site pain, headache, and transient breast tenderness. Less common but clinically relevant reactions can involve mood changes, dizziness, or mild gastrointestinal discomfort. Rarely, patients may experience allergic reactions that require immediate medical attention. Most side effects are dose‑related and tend to diminish with continued use. Patients should be advised to report any persistent or worsening symptoms to their clinician. For comprehensive safety data, healthcare professionals can consult the product’s prescribing information and the U.S. Food and Drug Administration database.

Warnings and Precautions

Gestone 50 mg Injection is contraindicated in individuals with known hypersensitivity to progesterone or any component of the formulation. Caution is advised in patients with a history of thromboembolic disorders, liver disease, or unexplained vaginal bleeding. The medication should not be used during pregnancy unless specifically prescribed for luteal support, and it must be discontinued if pregnancy is confirmed without a clear medical indication. Regular monitoring of blood hormone levels may be recommended to ensure therapeutic efficacy and safety. It is also important to inform the prescribing clinician of any other medications the patient is taking, as drug interactions can affect progesterone metabolism. Detailed precautionary statements are available on the manufacturer’s label and through professional medical resources.

Frequently Asked Questions

1. What condition does Gestone 50 mg Injection treat? It is primarily used to support the luteal phase in assisted reproduction and as part of hormone replacement therapy for selected infertility cases.

2. How is the injection administered? Gestone is typically given intramuscularly or subcutaneously, following the dosing schedule provided by a qualified healthcare professional.

3. Can Gestone be used with other fertility drugs? Yes, it is often combined with gonadotropins or other ovulation‑inducing agents, but the exact combination should be determined by a fertility specialist.

4. Is the medication safe for long‑term use? Clinical studies support its safety when used according to prescribed regimens, but long‑term therapy should be monitored regularly by a physician.

5. Where can I find more detailed prescribing information? Full prescribing details are published by Ferring Pharmaceuticals and can be accessed through medical reference sites such as MedlinePlus.

Additional Resources

For further reading on progesterone therapy and its role in reproductive health, reputable sources include the National Institutes of Health, the FDA, and peer‑reviewed articles indexed in PubMed. These resources provide evidence‑based guidance on the appropriate use of hormonal medications and can help patients and clinicians make informed decisions.

Related Products

• Acto Pred Tablet (Methylprednisolone)
• Acto Pred 16 mg (Methylprednisolone)
• Acto Pred 4 mg (Methylprednisolone)
• Pentasa Granules 2g (Mesalamine)
• Pentasa Granules 1g (Mesalamine)
• Pentasa Suppository 1g (Mesalamine)
• Pentasa (Mesalamine)
• Pentasa 500 mg (Mesalamine)
• Mesalamine 500 mg (Generic)
• Mesalamine Suppository 1g (Generic)
• Desmopressin 120mcg (Generic)
• Desmopressin 0.2mg (Generic)